“Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s52. Accessed April 18, 2026. https://skin.dermsquared.com/skin/article/view/1807.